Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

New England Journal of Medicine

Volumn 346, Issue 7, 2002, Pages 476-483

  Seshadri, Sudha ^a   Beiser, Alexa ^b   Selhub, Jacob ^c   Jacques, Paul F ^c   Rosenberg, Irwin H ^c   D'Agostino, Ralph B ^d   Wilson, Peter W F ^a   Wolf, Philip A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c TUFTS UNIVERSITY   (United States)

^d Boston University

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

AGED; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ARTICLE; DEMENTIA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DEMENTIA; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 0037075257     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa011613     Document Type: Article

References (56)

1. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset
2. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
3. Vascular risk factors for Alzheimer's disease: An epidemiologic perspective
4. Brain infarction and the clinical expression of Alzheimer disease: The Nun Study
5. Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study
6. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women
7. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
8. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis
9. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men
10. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham Study
11. Randomized trial of folic acid supplementation and serum homocysteine levels
12. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis
13. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people
14. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study
15. Identification of cognitive impairment in the elderly: Homocysteine is an early marker
16. Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey
17. Total serum homocysteine in senile dementia of Alzheimer type
18. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer's disease
19. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam Study
20. Hyperhomocysteinemia: A new risk factor for Alzheimer disease?
21. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study
22. Lifetime risk of dementia and Alzheimer's disease: The impact of mortality on risk estimates in the Framingham Study
23. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician
24. Clinical Dementia Rating (CDR)
25. Clinical diagnosis of Alzheimer's disease: Report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
26. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection
27. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
28. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms
29. Frequency of ApoB and ApoE gene mutations as causes of hypobetalipoproteinemia in the Framingham offspring population
30. Lactobacillus casei microbiological assay of folic acid derivatives in 96-well microtiter plates
31. Pyridoxal-5′-phosphate determination by a sensitive micromethod in human blood, urine and tissues: Its relation to cystathioninuria in neuroblastoma and biliary atresia
32. Alcohol consumption and cognitive performance in the Framingham Heart Study
33. Hyperhomocysteinaemia - A common finding in a psychogeriatric population
34. Age and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation
35. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham Study
36. Low serum vitamin B12 in Alzheimer-type dementia
37. Low serum cobalamin levels in primary degenerative dementia: Do some patients harbor atypical cobalamin deficiency states?
38. Vitamin B12 levels in serum and cerebrospinal fluid of people with Alzheimer's disease
39. Folate, vitamin B12 and cognitive impairment in patients with Alzheimer's disease
40. Vitamin B(12) and folate in relation to the development of Alzheimer's disease
41. The occurrence of lung cancer in man
42. Homocysteine in cerebral macroangiography and microangiopathy
43. Homocysteine and atherothrombosis
44. Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults
45. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine
46. The nitric oxide hypothesis of brain aging
47. Aging, energy, and oxidative stress in neurodegenerative diseases
48. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor
49. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: Possible risk factors in the Alzheimer's-type neurodegenerative pathways
50. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity
51. Hyperhomocysteinaemia
52. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials
53. Amendment of standards of identity for enriched grain products to require additional folic acid
54. The effect of folic acid fortification on plasma folate and total homocysteine concentrations